{"id":534784,"date":"2021-09-07T08:05:15","date_gmt":"2021-09-07T12:05:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\/"},"modified":"2021-09-07T08:05:15","modified_gmt":"2021-09-07T12:05:15","slug":"viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\/","title":{"rendered":"Viracta Therapeutics to Present at Upcoming Investor Conferences in September"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n SAN DIEGO<\/span>, Sept. 7, 2021<\/span> \/PRNewswire\/ —\u00a0Viracta<\/a>\u00a0Therapeutics, Inc. (NASDAQ: VIRX), a precision oncology company targeting virus-associated malignancies, today\u00a0<\/i>announced that company management will present and be available for virtual one-on-one meetings at the H.C. Wainwright 23rd<\/sup> Annual Global Investment Conference, September 13<\/span> \u2013 15, 2021, the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit, September 20<\/span> \u2013 23, 2021, and the 2021 Cantor Virtual Global Healthcare Conference, September 27<\/span> \u2013 30, 2021.<\/p>\n

Details on the presentations can be found below. <\/p>\n

\n\n\n\n
\n

\n
\n H.C. Wainwright 23rd Annual Global Investment Conference<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Presentation Date: <\/span>\n <\/p>\n<\/td>\n

\n

\n Corporate presentation will be available on-demand to conference
registrants starting at 7:00 AM ET on September 13, 2021<\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\u00a0<\/p>\n

\n\n\n\n\n\n\n
\n

\n
\n Oppenheimer Fall Healthcare Life Sciences & MedTech Summit<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Presentation Date:<\/span>\n <\/p>\n<\/td>\n

\n

\n September 21, 2021<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Presentation Time:<\/span>\n <\/p>\n<\/td>\n

\n

\n 4:35 PM ET<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Format:<\/span>\n <\/p>\n<\/td>\n

\n

\n Corporate presentation<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Webcast Link:<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n https:\/\/wsw.com\/webcast\/oppenheimer16\/virx\/2836187<\/a>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\u00a0<\/p>\n

\n\n\n\n\n\n
\n

\n
\n 2021 Cantor Virtual Global Healthcare Conference<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Presentation Date:<\/span>\n <\/p>\n<\/td>\n

\n

\n September 30, 2021<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Presentation Time:<\/span>\n <\/p>\n<\/td>\n

\n

\n 8:40 AM ET<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Format: <\/span>\n <\/p>\n<\/td>\n

\n

\n Corporate presentation<\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

A replay of the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit presentation will be available on the “Events and Webcasts” section of the Viracta website at https:\/\/viracta.investorroom.com\/events-and-webcasts<\/a>. <\/p>\n

\n About Viracta Therapeutics, Inc.
<\/b>Viracta is a precision oncology company targeting virus-associated malignancies. Viracta’s proprietary investigational drug, nanatinostat, is currently being evaluated in combination with the antiviral agent valganciclovir as an oral combination therapy in two Phase 2 clinical trials for EBV-positive lymphoma. Viracta is also pursuing application of its inducible synthetic lethality approach in other EBV-associated malignancies, such as nasopharyngeal carcinoma, gastric carcinoma, and other virus-related cancers.<\/p>\n

For additional information please visit\u00a0www.viracta.com<\/a>.<\/p>\n

\n\n\n\n\n\n\n
\n

\n
\n Investor Relations Contact: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n Company Contact:<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Joyce Allaire\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span>\n <\/p>\n<\/td>\n

\n

\n Dan Chevallard<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n LifeSci Advisors\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span>\n <\/p>\n<\/td>\n

\n

\n Chief Operating Officer and Chief Financial Officer<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n jallaire@lifesciadvisors.com<\/a>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n
\n dchevallard@viracta.com<\/a>\u00a0<\/u>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n (212) 915-2569\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span>\n <\/p>\n<\/td>\n

\n

\n (858) 771-4193<\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\u00a0<\/p>\n

\n

\n
\n \"Viracta
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\u00a0<\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september-301370207.html<\/a><\/p>\n

SOURCE Viracta<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire SAN DIEGO, Sept. 7, 2021 \/PRNewswire\/ —\u00a0Viracta\u00a0Therapeutics, Inc. (NASDAQ: VIRX), a precision oncology company targeting virus-associated malignancies, today\u00a0announced that company management will present and be available for virtual one-on-one meetings at the H.C. Wainwright 23rd Annual Global Investment Conference, September 13 \u2013 15, 2021, the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit, September 20 \u2013 23, 2021, and the 2021 Cantor Virtual Global Healthcare Conference, September 27 \u2013 30, 2021. Details on the presentations can be found below. H.C. Wainwright 23rd Annual Global Investment Conference Presentation Date: Corporate presentation will be available on-demand to conference registrants starting at 7:00 AM ET on September 13, 2021 \u00a0 Oppenheimer Fall Healthcare Life Sciences & MedTech Summit Presentation Date: September … <\/p>\n

Continue reading “Viracta Therapeutics to Present at Upcoming Investor Conferences in September”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-534784","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nViracta Therapeutics to Present at Upcoming Investor Conferences in September - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Viracta Therapeutics to Present at Upcoming Investor Conferences in September - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire SAN DIEGO, Sept. 7, 2021 \/PRNewswire\/ —\u00a0Viracta\u00a0Therapeutics, Inc. (NASDAQ: VIRX), a precision oncology company targeting virus-associated malignancies, today\u00a0announced that company management will present and be available for virtual one-on-one meetings at the H.C. Wainwright 23rd Annual Global Investment Conference, September 13 \u2013 15, 2021, the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit, September 20 \u2013 23, 2021, and the 2021 Cantor Virtual Global Healthcare Conference, September 27 \u2013 30, 2021. Details on the presentations can be found below. H.C. Wainwright 23rd Annual Global Investment Conference Presentation Date: Corporate presentation will be available on-demand to conference registrants starting at 7:00 AM ET on September 13, 2021 \u00a0 Oppenheimer Fall Healthcare Life Sciences & MedTech Summit Presentation Date: September … Continue reading "Viracta Therapeutics to Present at Upcoming Investor Conferences in September"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-07T12:05:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/872134\/Viracta_Therapeutics_Inc_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Viracta Therapeutics to Present at Upcoming Investor Conferences in September\",\"datePublished\":\"2021-09-07T12:05:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\\\/\"},\"wordCount\":294,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/872134\\\/Viracta_Therapeutics_Inc_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\\\/\",\"name\":\"Viracta Therapeutics to Present at Upcoming Investor Conferences in September - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/872134\\\/Viracta_Therapeutics_Inc_Logo.jpg\",\"datePublished\":\"2021-09-07T12:05:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/872134\\\/Viracta_Therapeutics_Inc_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/872134\\\/Viracta_Therapeutics_Inc_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Viracta Therapeutics to Present at Upcoming Investor Conferences in September\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Viracta Therapeutics to Present at Upcoming Investor Conferences in September - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\/","og_locale":"en_US","og_type":"article","og_title":"Viracta Therapeutics to Present at Upcoming Investor Conferences in September - Market Newsdesk","og_description":"PR Newswire SAN DIEGO, Sept. 7, 2021 \/PRNewswire\/ —\u00a0Viracta\u00a0Therapeutics, Inc. (NASDAQ: VIRX), a precision oncology company targeting virus-associated malignancies, today\u00a0announced that company management will present and be available for virtual one-on-one meetings at the H.C. Wainwright 23rd Annual Global Investment Conference, September 13 \u2013 15, 2021, the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit, September 20 \u2013 23, 2021, and the 2021 Cantor Virtual Global Healthcare Conference, September 27 \u2013 30, 2021. Details on the presentations can be found below. H.C. Wainwright 23rd Annual Global Investment Conference Presentation Date: Corporate presentation will be available on-demand to conference registrants starting at 7:00 AM ET on September 13, 2021 \u00a0 Oppenheimer Fall Healthcare Life Sciences & MedTech Summit Presentation Date: September … Continue reading \"Viracta Therapeutics to Present at Upcoming Investor Conferences in September\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-07T12:05:15+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/872134\/Viracta_Therapeutics_Inc_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Viracta Therapeutics to Present at Upcoming Investor Conferences in September","datePublished":"2021-09-07T12:05:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\/"},"wordCount":294,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/872134\/Viracta_Therapeutics_Inc_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\/","name":"Viracta Therapeutics to Present at Upcoming Investor Conferences in September - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/872134\/Viracta_Therapeutics_Inc_Logo.jpg","datePublished":"2021-09-07T12:05:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/872134\/Viracta_Therapeutics_Inc_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/872134\/Viracta_Therapeutics_Inc_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viracta-therapeutics-to-present-at-upcoming-investor-conferences-in-september\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Viracta Therapeutics to Present at Upcoming Investor Conferences in September"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/534784","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=534784"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/534784\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=534784"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=534784"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=534784"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}